Ascensia Diabetes Care
46
0
0
46
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 46 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
91%
42 of 46 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (46)
Evaluation of the Performance of CONTOUR NEXT® and CONTOUR PLUS ELITE® BGMS in Neonates Using Capillary Blood Samples
Role: lead
Performance of Contour Next® and Contour Plus Elite® BGMS in Arterial Blood Samples From Hospitalized Adults
Role: lead
Evaluation of DIDGET TM World Reports
Role: lead
User Performance of the Thunder Plus BGMS
Role: lead
Performance of the L-PLUS BGMS by Persons With Diabetes Mellitus
Role: lead
Ketostix® and Keto-Diastix® Performance Study
Role: lead
User Performance of the TV4 BGMS
Role: lead
The International Diabetes Closed Loop (iDCL) Trial: Protocol 1
Role: collaborator
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
Role: lead
Evaluation of an Ascensia Diabetes Care ONYX PLUS Investigational Blood Glucose Monitoring System
Role: lead
Evaluation of a Ascensia ONYX NEXT Investigational Blood Glucose Monitoring System
Role: lead
Evaluation of an Ascensia Diabetes Care Blood Glucose Meter and App System
Role: lead
User Performance Evaluation of Contour® Next One, Accu-Chek® Aviva Connect, FreeStyle Freedom Lite, OneTouch® Verio and GlucoMen® Areo Blood Glucose Monitoring Systems Following ISO 15197:2013
Role: collaborator
Evaluation of an Ascensia Blood Glucose Meter and App System
Role: lead
Evaluation of an Ascensia Lancing System
Role: lead
Evaluation of Blood Glucose Monitoring Systems With Blood Samples From Neonates
Role: lead
User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015
Role: collaborator
Evaluation of an Investigational Blood Glucose Monitoring System
Role: lead
A New Glucose Meter With Alternative Site Testing
Role: lead
Performance of an Investigational Blood Glucose Monitoring System in a Clinical Setting
Role: lead